These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37662550)

  • 1. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease.
    Devi G
    Front Aging Neurosci; 2023; 15():1213968. PubMed ID: 37662550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
    Tahami Monfared AA; Ye W; Sardesai A; Folse H; Chavan A; Aruffo E; Zhang Q
    Neurol Ther; 2023 Jun; 12(3):863-881. PubMed ID: 37009976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants.
    Dubois B; von Arnim CAF; Burnie N; Bozeat S; Cummings J
    Alzheimers Res Ther; 2023 Oct; 15(1):175. PubMed ID: 37833762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases.
    Marsool MDM; Prajjwal P; Reddy YB; Marsool ADM; Lam JR; Nandwana V
    Dis Mon; 2023 May; 69(5):101547. PubMed ID: 36931947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating the Alzheimer's Treatment Landscape: Unraveling Amyloid-Beta Complexities and Pioneering Precision Medicine Approaches.
    Patwekar M; Patwekar F; Khan S; Sharma R; Kumar D
    Curr Top Med Chem; 2024 Apr; ():. PubMed ID: 38644708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Spina S; La Joie R; Petersen C; Nolan AL; Cuevas D; Cosme C; Hepker M; Hwang JH; Miller ZA; Huang EJ; Karydas AM; Grant H; Boxer AL; Gorno-Tempini ML; Rosen HJ; Kramer JH; Miller BL; Seeley WW; Rabinovici GD; Grinberg LT
    Brain; 2021 Aug; 144(7):2186-2198. PubMed ID: 33693619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab.
    Shi M; Chu F; Zhu F; Zhu J
    Front Aging Neurosci; 2022; 14():870517. PubMed ID: 35493943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].
    Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):38-44. PubMed ID: 36412155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Ossenkoppele R; van der Kant R; Hansson O
    Lancet Neurol; 2022 Aug; 21(8):726-734. PubMed ID: 35643092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision pharmacology for Alzheimer's disease.
    Hampel H; Vergallo A; Aguilar LF; Benda N; Broich K; Cuello AC; Cummings J; Dubois B; Federoff HJ; Fiandaca M; Genthon R; Haberkamp M; Karran E; Mapstone M; Perry G; Schneider LS; Welikovitch LA; Woodcock J; Baldacci F; Lista S;
    Pharmacol Res; 2018 Apr; 130():331-365. PubMed ID: 29458203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.
    Freudenberg-Hua Y; Li W; Davies P
    Front Med (Lausanne); 2018; 5():108. PubMed ID: 29740579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain β-amyloid pathology.
    Pan F; Huang Y; Cai X; Wang Y; Guan Y; Deng J; Yang D; Zhu J; Zhao Y; Xie F; Fang Z; Guo Q
    Commun Med (Lond); 2023 May; 3(1):65. PubMed ID: 37165172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Major Hypotheses of Alzheimer's Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment.
    Cáceres C; Heusser B; Garnham A; Moczko E
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067098
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.